Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05821049
Other study ID # UI/220902/UP/SQMS
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 4, 2023
Est. completion date December 8, 2023

Study information

Verified date April 2024
Source Vedic Lifesciences Pvt. Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomized, double blind, placebo controlled, parallel group study to evaluate the efficacy of UP165 on sleep quality and mood state in healthy adults


Recruitment information / eligibility

Status Completed
Enrollment 175
Est. completion date December 8, 2023
Est. primary completion date December 8, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria: - Male and female subjects =20 and = 60 years' old with moderate physical activity level as per International Physical Activity Questionnaire - Short Form(IPAQ - SF) - Volunteers with body mass index between 18.5 and 29.9 kg/m2. Fairly bad or very bad subjective sleep quality with a score of 2 or 3 assessed as per PSQI Q9. - Willing to maintain current dietary pattern, activity level, and stable bodyweight for the duration of the study, and refrain from any drastic lifestyle changes. - Unable to fall asleep or unable to stay asleep (2 or more waking episodes during sleep at least twice a week but not more than four times) - Agrees to maintain current sleep schedule throughout the study - Agrees to stay in the current time zone for the duration of the study - Subjects ready to give voluntary, written, informed consent to participate in the study. - Willing to complete all study procedures including study-related questionnaires and comply with study requirements. Exclusion Criteria: - Subjects diagnosed with sleep disorders secondary to another health problem. - Consumption of hypnotic drugs (<3 months before inclusion). - Subjects with a history of caffeine consumption post 6:00 pm. - Individuals taking any other sleep supplements and are unwilling to stop taking those supplements for the duration of the study period - Recent history of physical, emotional, social trauma within last three months. - Participants who are not medication (which are likely to impact sleep quality or pattern) free for at least 4 weeks apart from contraceptive pills - Subjects who consume pain-relieving medications more than once per week. - Individuals who have night terrors regularly - Individuals who regularly sleepwalk - Individuals who work at night shifts. - Individuals who have regular bad dreams - Use of the following medications during the study period: oral or injectable corticosteroid, sedating antihistamines (e.g. cold, allergy, motion sickness), psychotropic medications or hypnotics, benzodiazepine, narcotics, any illicit drugs - Gastro-intestinal, hepatic, respiratory, psychiatric, kidney, or cardiovascular disorder (<3 months before inclusion), - Recent (<3 months before inclusion) change in lifestyle (food, body weight, sport, drug, and/or dietary supplement), - Students having regular class and assignments - Subjects addicted to digital media who exhibit at least five of the following symptoms currently: i) Preoccupation with the digital media use j) Withdrawal symptoms that occur when digital media use is not possible k) Build-up of a tolerance that requires increasing amounts of digital media use to satisfy cravings l) Unsuccessful attempts to stop or limit digital media use m) Replacement of previously pleasurable activities with digital media use n) Unwillingness to stop digital media use despite its negative consequences o) Being deceptive about digital media use p) Using digital media use as a coping mechanism - Addiction or history of substance abuse, - Consumption of more than 3 glasses of alcohol per day, - Pregnant or lactating woman, - Lifestyle habits which would modify the wake-sleep rhythm, or which was expected to be modified during the study period (e.g., night work), and finally, - Known allergy to the IP.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
UPI65 (Low Dose)
Red colored Capsules
UP165 (High Dose)
Red colored Capsules
Placebo
Red colored Capsules

Locations

Country Name City State
India Poojan Multispeciality Hospital Ahmedabad Maharashtra
India V.S. General Hospital Ahmedabad Gujarat
India Shree Ashirwad Hospital Dombivli Maharashtra
India Maharaja Agrasen Superspeciality Hospital Jaipur Rajasthan
India Sai Cititcare Ulhasnagar Maharashtra
India Aman Hospital and Research Center Vadodara Gujarat

Sponsors (1)

Lead Sponsor Collaborator
Vedic Lifesciences Pvt. Ltd.

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary To assess the efficacy of the Investigational Product (IP) from baseline on Sleep statistics (sleep quality thoughout the study) by using the watch known as Garmin vivosmart 4 Tracker. This watch will be used to measure the deep sleep, REM sleep and wake-up time in hours. throughout the study period (approximately 28 days)
Primary To assess the efficacy of the Investigational Product (IP) from baseline on The change in sleep index through the global scores of the Pittsburgh Sleep Quality Index (PSQI) Day 28
Primary To assess the efficacy of the Investigational Product (IP) from baseline on The change in sleep index through the global scores of the Pittsburgh Sleep Quality Index (PSQI) Day 21
Primary To assess the efficacy of the Investigational Product (IP) from baseline on The change in sleep index through the global scores of the Pittsburgh Sleep Quality Index (PSQI) Day 14
Primary To assess the efficacy of the Investigational Product (IP) from baseline on The change in sleep index through the global scores of the Pittsburgh Sleep Quality Index (PSQI) Day 7
Primary To assess the efficacy of the Investigational Product (IP) from baseline on Mood using POMS-A (Profile of Moods States - Abbreviated version) Day 28
Primary To assess the efficacy of the Investigational Product (IP) from baseline on Mood using POMS-A (Profile of Moods States - Abbreviated version) Day 21
Primary To assess the efficacy of the Investigational Product (IP) from baseline on Mood using POMS-A (Profile of Moods States - Abbreviated version) Day 14
Primary To assess the efficacy of the Investigational Product (IP) from baseline on Mood using POMS-A (Profile of Moods States - Abbreviated version) Day 7
Primary To assess the efficacy of the Investigational Product (IP) from baseline on Salivary cortisol levels immediately after waking up in the morning (before doing any activity) Day 28
Primary To assess the efficacy of the Investigational Product (IP) from baseline on Salivary cortisol levels immediately after waking up in the morning (before doing any activity) Day 21
Primary To assess the efficacy of the Investigational Product (IP) from baseline on Salivary cortisol levels immediately after waking up in the morning (before doing any activity) Day 14
Primary To assess the efficacy of the Investigational Product (IP) from baseline on Salivary cortisol levels immediately after waking up in the morning (before doing any activity) Day 7
See also
  Status Clinical Trial Phase
Completed NCT04959214 - The Effect Of Progressıve Relaxatıon Exercıses N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Completed NCT05555186 - The Effects of Bright Light Therapy on Adolescent's Sleep Quality and Well-being N/A
Completed NCT05093465 - A Comparison of Two Behavioral Sleep Interventions Among College Students (ProjectTECH) N/A
Completed NCT03673397 - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression N/A
Recruiting NCT04368416 - Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
Completed NCT04566822 - Calm Sleep Coaching N/A
Not yet recruiting NCT06406309 - Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD N/A
Recruiting NCT00860756 - Sleep Disturbance in Deployed Soldiers Phase 0
Recruiting NCT05699837 - Alpha Entrainment for Pain and Sleep (Extension) N/A
Completed NCT06108115 - Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering From Alcohol Use Disorder N/A
Completed NCT05511818 - Radicle Rest: A Study of Cannabinoids on Sleep and Health Outcomes N/A
Completed NCT04560595 - Remote Guided Caffeine Reduction N/A
Not yet recruiting NCT06104280 - Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment N/A
Enrolling by invitation NCT04290650 - Sleep Disturbances in Patients With Psychotic Symptoms (AkuSleep) N/A
Recruiting NCT04207502 - Integrating Systematic Data of Geriatric Medicine to Explore the Solution for Health Aging
Suspended NCT03908905 - Sleep Disturbances and Chronic Widespread Pain
Completed NCT03269760 - Multimodal Sleep Pathway for Shoulder Arthroplasty Phase 1
Completed NCT04990206 - Improving Sleep Health in Adults With Overweight or Obesity N/A
Completed NCT03112824 - Functional Assessment of Ashwagandaha Root Extract During Weight Loss N/A